Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1069 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2024-10-14 (marketbeat.com)
Charles River Laboratories International (NYSE:CRL) Earns Sell Rating from Analysts at Redburn Atlantic
Redburn Atlantic began coverage on shares of Charles River Laboratories International in a research note on Monday. They issued a "sell" rating for the company.
Read more
2024-10-01 (investing.com)
Citi Downgrades Charles River Labs to Sell and Severes Price Target From Investing.com
Citi Downgrades Charles River Labs to Sell and Severes Price Target
Read more
2024-06-26 (fitchratings.com)
Fitch Affirms Charles River Laboratories International, Inc. at 'BBB-'; Outlook Stable
Fitch Ratings-New York-26 June 2024: Fitch Ratings has affirmed Charles River Laboratories International, Inc.'s (parent) and certain of its subsidiarie.
Read more
2023-07-10 (marketbeat.com)
Citigroup Lowers Charles River Laboratories International (NYSE:CRL) to Neutral
Citigroup cut shares of Charles River Laboratories International from a "buy" rating to a "neutral" rating in a research report on Monday.
Read more
2023-05-05 (marketbeat.com)
Charles River Laboratories International (NYSE:CRL) Lowered to Hold at StockNews.com
StockNews.com lowered Charles River Laboratories International from a "buy" rating to a "hold" rating in a research note on Friday.
Read more
2023-01-10 (reporter.am)
Charles River Laboratories International (NYSE:CRL) versus OmniAb (NASDAQ:OABI) Head to Head Comparison
Charles River Laboratories International (NYSE:CRL – Get Rating) and OmniAb (NASDAQ:OABI – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings,
Read more
2022-12-19 (reporter.am)
Amundi Raises Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Amundi boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 34.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission.
Read more
2022-10-07 (reporter.am)
Allspring Global Investments Holdings LLC Raises Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Allspring Global Investments Holdings LLC boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 1,739.4% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 645,263 shares of the
Read more
2022-07-18 (fitchratings.com)
Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc.’s (CRL) ‘BBB–’ Issuer Default Rating reflects its strong position as a leading drug discovery, nonclinical devel
Read more